Efficacy of l-Arginine treatment in patients with HTLV-1-associated neurological disease

by | Dec 22, 2022 | Publications

Ann Clin Transl Neurol. 2022 Dec 22. doi: 10.1002/acn3.51715. Online ahead of print.

NO ABSTRACT

Decoding pathogenesis factors

Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a...

HTLV-1 Disease Abstract The years 2020 and 2021 will remain memorable years for many reasons [...]. Click here to...

HTLV-2 Encoded Antisense Protein APH-2 Suppresses HIV-1 Replication Abstract Antisense protein of Human T-cell...